Rheumatology Associates, P.C. is moving

We will see patients in our new
location beginning September 13, 2022

Your scheduled appointment will not change

12 Office Park Circle
Mountain Brook, AL 35223


Open your cell phone camera and hover over the QR Code below for directions:

QR code for directions

Anthony M. Turkiewicz, M.D.

Anthony M. Turkiewicz, M.D.


Georgetown University School of Medicine
Degree: Doctor of Medicine

Georgetown University
Degree: Bachelor of Science in Biology, cum laude, with a minor in Music Performance


Georgetown University Medical Center
Department of Internal Medicine


Georgetown University Medical Center
Department of Rheumatology, Immunology, and Allergy
National Institutes of Health (NIH) Intramural Research Training Award


Rheumatology, American Board of Internal Medicine
Internal Medicine, American Board of Internal Medicine
Clinical Densitometry, The International Society of Clinical Densitometry (ISCD)

Selected Publications:

P. Mease, A. Deodhar, R. Fleischmann, D. Gladman, A. Turkiewicz, D. van derHeijde, et al. Effect of Certolizumab Pegol over 96 Weeks in Patients with Psoriatic Arthritis with and without Prior Anti-Tumor Necrosis Factor Exposure.Submitted for publication, July 2014.

Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Turkiewicz AM, et al.Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis. N Engl J Med 2010 July 15;363(3):221-32.

Wolfe F, Clauw DJ, Fitzcharles MA, et al.The American College of Rheumatology Preliminary Diagnostic Criteria for Fibromyalgia and Measurement of Symptom Severity. Arthritis Rheum. 2010 May 15;62(5):600-610.

Saag KG, Teng GG, Patkar NM, Paulus, HE, Hochberg M, Mikuls T, Moreland LW, O’Dell J, Turkiewicz AM, and Furst DE.2008 ACR Recommendations for the Use of Non-biologic and Biologic Therapies in Rheumatoid Arthritis.Arthritis Rheum. 2008Jun 15;59(6):762-84.

Turkiewicz AM and Khan MA.Ankylosing Spondylitis: Disease Manifestations and the Utility of Biologics. In: Trivedi P, Hixon J, editors. Rheumatologic Disorders: Making the Difference With Biologic Therapy. 1st edition; Volume 1, Issue 3 of 6. New Jersey: Postgraduate Institute for Medicine; 2008.

Turkiewicz AM.Spondyloarthropathies and Associated Comorbidities: What else should we be looking for?Medscape Rheumatology Expert Column. 2007 Dec;

Turkiewicz AM and Moreland LW.Psoriatic Arthritis: Current Concepts on Pathogenesis-Oriented Therapeutic Principles. Arthritis Rheum. 2007 Apr; 56(4):1051-1066.

Khan MA, Clegg DO, Gabriel SE, Reveille JD, Turkiewicz AM, Weisman MH, and Davis, JC.Summary of the 2006 Annual Research and Education Meeting of the Spondyloarthritis Research and Therapy Network (SPARTAN). J Rheum 2007; 34(5):1118-1124.

Turkiewicz AM and Moreland LW.Rheumatoid Arthritis: Pathogenesis and Treatment. In: Bartlett SJ, Bingham CO, Maricic MJ, editors.Clinical Care in the Rheumatic Diseases. 3rd edition. Atlanta: American College of Rheumatology; 2006.p. 157-66.

Teng GG, Turkiewicz AM, Moreland LW.Abatecept: A Costimulatory Inhibitor for Treatment of Rheumatoid Arthritis.Exp Opin Biol Therapy. 2005 Sept; 5(9):1245-54.

Turkiewicz, AM andKerr G. Syrinx-Induced Charcot Shoulder. Arthritis Rheum2004 Jul; 50(7):2380.

Chatham, WW, Turkiewicz, AM, and Blackburn,WD “Determinants of neutrophil HOCL generation: ligand-dependentresponses and the role of surface adhesion.” J Leukoc Biol. 1994 Nov; 56(5):654-60.

Additional Information:

Dr. Turkiewicz joined Rheumatology Associates in 2007 where he serves as the Director of the Clinical Research Unit.  Prior to joining the practice, Dr. Turkiewicz served on the faculty of the Division of Clinical Immunology and Rheumatology at the University of Alabama at Birmingham (UAB) School of Medicine as an Assistant Professor of Medicine.  He was appointed Associate Director of the UAB Arthritis Clinical Research Program and a Senior Scientist in the Center for Aging.  Dr. Turkiewicz has served as principal investigator on over 40 clinical research protocols, including NIH-funded and investigator-initiated trials investigating the use of biologic response modifiers for the treatment of autoimmune diseases.  His research focus is the use of biologic therapies in rheumatoid arthritis, lupus, and spondyloarthropathy management, along with early diagnostic strategies for the spondyloarthropathies.

Dr. Turkiewicz is the recipient of a number of awards and honors including an ACR/REF Fellowship Training Award, the Washington DC Rheumatism Society Research Award, and a Clinical Immunology Society award.  He was elected to full membership in the Spondyloarthropathy Research and Treatment Network (SPARTAN) in 2005 and was appointied to the ACR Core Expert Panel Task Force on the Use of Biologics in Rheumatoid Arthritis.  He also has been named one of the Best Doctors in America since 2007.  In addition to his research and clinical activities, Dr. Turkiewicz serves on the Board of Directors of the Arthritis Foundation, Alabama/Southeast chapter and remains active in state and national arthritis education and advocacy initiatives.

His music studies at Georgetown University focused on conducting and piano and organ performance.  He studied piano with his father, Dr. Witold W. Turkiewicz and organ with Dr. Edward Tibbs during his time in Birmingham prior to leaving for Washington D.C. in 1991.  His 1992 debut organ recital in Washington D.C. was held at the John F. Kennedy Center for Performing Arts, after being awarded a Kennedy Center Scholarship and solo recital.  Dr. Turkiewicz remains active with music performance and teaching.  He and his wife, Eleanor Carroll, have three children.